At a glance
- Originator GlaxoSmithKline
- Class Antineoplastics; Gastric antisecretories
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 01 Mar 1995 Discontinued-Preclinical for Hypertension in United Kingdom (Unknown route)